Fortress Biotech, Inc. (FBIO)
NASDAQ: FBIO · IEX Real-Time Price · USD
2.180
+0.030 (1.40%)
Jul 22, 2024, 10:12 AM EDT - Market open
Fortress Biotech Employees
Fortress Biotech had 186 employees as of December 31, 2023. The number of employees decreased by 1 or -0.53% compared to the previous year.
Employees
186
Change (1Y)
-1
Growth (1Y)
-0.53%
Revenue / Employee
$457,602
Profits / Employee
-$337,930
Market Cap
44.91M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
NeueHealth | 1,252 |
Qilian International Holding Group | 298 |
BioXcel Therapeutics | 74 |
OncoCyte | 46 |
Envoy Medical | 34 |
Tempest Therapeutics | 17 |
Regencell Bioscience Holdings | 12 |
CalciMedica | 12 |
FBIO News
- 7 days ago - GC Cell and Checkpoint Therapeutics Advance Collaborative Cancer Research - GlobeNewsWire
- 10 days ago - Journey Medical Corporation Appoints Michael C. Pearce to Board of Directors - GlobeNewsWire
- 16 days ago - Fortress Biotech Announces Pause in Payment of Dividends on 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock - GlobeNewsWire
- 20 days ago - Checkpoint Therapeutics Announces $12 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 20 days ago - Checkpoint Therapeutics Announces Biologics License Application Resubmission for Cosibelimab - GlobeNewsWire
- 4 weeks ago - Checkpoint Therapeutics Announces Alignment with FDA Enabling Upcoming Cosibelimab BLA Resubmission - GlobeNewsWire
- 2 months ago - Fortress Biotech to Participate in the Alliance Global Partners' (A.G.P.) Virtual Healthcare Company Showcase - GlobeNewsWire
- 2 months ago - Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights - GlobeNewsWire